About DrAid ™ AI Cognitive Service

AI solution suites encompassing multiple modalities covering various anatomy (DrAid™ - Comprehensive Screening) and focus on cancer early detection and diagnosis (DrAid™ - Oncology Screening). No machine learning expertise is required.

Learn more about our product and request a demo.

Product Highlights

DrAid™ Chest XR: Comprehensive Chest Screening | Autonomous Screening Of 52 Abnormalities

Focuses on Chest X-ray for 52 abnormities with 91% accuracy
Classification of normal & abnormal cases
Triage & Prioritization
Workflow Management
AI and ChatGPT/GPT* copilot combine for end-to-end generative medical reports
Sensitivity – 97% | Specificity - 95%

DrAid™ Liver cancer CT: Oncology Screening | Segmentation & Classification of liver lesions using multiphase CT

Segmentation & classification of liver CT studies into normal & abnormal
4 types of findings: Hepatocellular Carcinoma (HCC), Malignant lesions other than HCC, Benign lesions and Ambiguous lesions
Dice Score for liver segmentation: 96,55%
Dice Score for tumor segmentation: 74,47%
F1 Score for tumor classification: 90,12%

Why DrAid™ AI Cognitive Service?

This is the ideal solution for radiologists, diagnostic imaging machine manufacturers, software developers, system integrators, and AI researchers looking for new AI capabilities with a low cost of entry.

Click on the "Contact me" button to start with DrAid™ Cognitive services today.

DrAid™ is the first medical device for chest X-ray diagnosis powered by AI in Southeast Asia that got FDA Clearance.

DrAid™ AI Cognitive ServiceVINBRAIN JOINT STOCK COMPANY

DrAid™ AI Cognitive Service

VINBRAIN JOINT STOCK COMPANY

DrAid™ AI Cognitive Service

VINBRAIN JOINT STOCK COMPANY

DrAid™ AI Cognitive Service
VINBRAIN JOINT STOCK COMPANY